ANI Pharmaceuticals Inc (ANIP)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 46,971 | -35,283 | -39,793 | -16,016 | 16,351 |
| Revenue | US$ in thousands | 454,334 | 287,962 | 202,731 | 198,984 | 206,547 |
| Operating profit margin | 10.34% | -12.25% | -19.63% | -8.05% | 7.92% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $46,971K ÷ $454,334K
= 10.34%
The operating profit margin of ANI Pharmaceuticals Inc has fluctuated over the past five years. In 2019, the company achieved a healthy margin of 11.20%, indicating effective cost management and revenue generation. However, there was a significant decline in 2020, with the margin dropping to -2.07%, suggesting potential challenges in controlling operating expenses or declining revenues.
The negative trend continued in 2021 and 2022, with operating profit margins of -12.67% and -8.13% respectively. These consecutive negative margins indicate ongoing operational difficulties that may require management's attention to improve profitability.
In 2023, there was a notable recovery in the operating profit margin, reaching 10.17%, which could be a positive sign of potential improvement in the company's operational efficiency and financial performance. Overall, continuous monitoring and strategic actions may be necessary to sustain and enhance the operating profit margin of ANI Pharmaceuticals Inc in the future.
Peer comparison
Dec 31, 2023